04/25/2024 3:40 PM | Fairmount Funds Management LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13D/A | |
04/25/2024 3:55 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 5:22 PM | Avoro Capital Advisors LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
04/18/2024 7:24 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/01/2024 11:15 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form EFFECT | |
04/01/2024 11:15 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form EFFECT | |
03/20/2024 6:14 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form PRE 14A | |
|
03/18/2024 7:31 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:19 AM | FMR LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
03/01/2024 5:14 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-K/A | |
02/29/2024 4:06 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024 3:07 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2024 8:21 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Turtle Cameron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:47 PM | Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 3:37 PM | EcoR1 Capital, LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 8:08 AM | Avoro Capital Advisors LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 7:56 AM | Deep Track Capital, LP (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 6:02 AM | RTW INVESTMENTS, LP (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
02/13/2024 5:46 PM | BCLS II Equity Opportunities, LP (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 8:39 AM | Polar Capital Holdings Plc (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 9:20 AM | FMR LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
02/08/2024 3:36 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024 8:37 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 424B3 | |
02/05/2024 4:25 PM | McKenna Mark C. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/05/2024 4:29 PM | McKenna Mark C. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:36 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 7:23 PM | King-Jones Heidy (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:27 PM | Burrows Scott L (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:31 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Turtle Cameron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:26 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 4:00 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Fairmount Funds Management LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13D/A | |
12/26/2023 8:56 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/22/2023 5:00 PM | Burrows Scott L (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:00 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/22/2023 3:32 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/13/2023 2:50 PM | PERCEPTIVE ADVISORS LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13G | |
12/11/2023 4:41 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 7:45 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 4:18 PM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 424B3 | |
11/29/2023 4:08 PM | Fairmount Funds Management LLC (Filed by) Spyre Therapeutics, Inc. (Subject) Spyre Therapeutics (Subject)
| Form SC 13D/A | |
4 coins to be the “Next Bitcoin” (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
11/28/2023 6:33 AM | Spyre Therapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 3:27 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Stelzer Laurie (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/27/2023 3:32 PM | Albers Jeffrey W. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/27/2023 3:33 PM | Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Stelzer Laurie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 3:36 PM | Albers Jeffrey W. (Reporting) Spyre Therapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 7:45 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2023 11:15 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form EFFECT | |
11/15/2023 4:14 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2023 4:18 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1/A | |
11/14/2023 2:13 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Deutsch Peter E. (Filed by)
| Form SC 13G | |
10/26/2023 8:53 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form DEF 14A | |
10/24/2023 8:00 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 8:36 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 8:40 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form PRER14A | |
10/06/2023 8:45 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form S-1/A | |
10/05/2023 4:13 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 3:02 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2023 4:05 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:15 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) King-Jones Heidy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:06 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Burrows Scott L (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 3:10 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Burrows Scott L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:10 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) King-Jones Heidy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 6:06 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:01 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:02 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:07 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023 8:51 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form PRE 14A | |
07/28/2023 8:01 AM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
07/27/2023 6:01 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:01 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Logos Global Management LP (Filed by)
| Form SC 13G | |
07/14/2023 3:05 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 3:16 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
07/03/2023 3:20 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Affinity Asset Advisors, LLC (Filed by)
| Form SC 13G | |
06/30/2023 4:24 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) Fairmount Funds Management LLC (Filed by)
| Form SC 13D | |
06/30/2023 4:32 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/30/2023 4:13 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/30/2023 4:14 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Turtle Cameron (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/30/2023 3:30 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Lawton Alison Frances (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:31 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Smith Hunter C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:32 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Magovcevic-Liebisch Ivana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:33 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Cox Russell J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:34 PM | Aeglea BioTherapeutics, Inc. (Issuer) Spyre Therapeutics (Issuer) Alspaugh Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 3:20 PM | Aeglea BioTherapeutics, Inc. (Subject) Spyre Therapeutics (Subject) EcoR1 Capital Fund Qualified, L.P. (Filed by)
| Form SC 13G | |
06/23/2023 8:16 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2023 4:20 PM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 6:01 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 6:05 AM | Aeglea BioTherapeutics, Inc. (Filer) Spyre Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |